“We deliberately delayed our entrance to the pharmacies a little bit in order to provide a more reasonable price.
We announced yesterday that our price will be about 8 thousand rubles, which is 30% lower than that of analogs, "RIA Novosti quoted him as saying.
As noted by Dmitriev, RDIF will work to reduce prices.
He also stressed that the medicine is available free of charge in hospitals.
At the end of May, Avifavir with the active ingredient favipiravir received a registration certificate from the Ministry of Health.